Stocks & ETFs Screener: 200+ results (Biotechnology)

Symbol	Industry	Market Cap	Fund. Score	Div. Score	Tech. Score	P/E	Return 12m vs S&P 500
ABBV AbbVie	Biotechnology Biologics, Immunology, Oncology	411B	50.7%	68.9%	87.0%	176	26.6%
AMGN Amgen	Biotechnology Rheumatoid Arthritis, Psoriasis	181B	82.4%	67.9%	52.5%	26.0	7.01%
GILD Gilead Sciences	Biotechnology Antivirals, Oncology, Hepatitis	155B	83.5%	65.5%	86.9%	19.4	29.8%
VRTX Vertex	Biotechnology Cystic Fibrosis, Sickle Cell, Beta	110B	87.3%	-	20.8%	30.6	-16.3%
REGN Regeneron	Biotechnology Eylea, Dupixent, Libtayo	73.0B	79.6%	14.9%	-17.4%	16.7	-16.4%
ALNY Alnylam	Biotechnology RNAi Therapeutics, Patisiran	60.0B	60.3%	-	86.8%	-	60.2%
ARGX argenx	Biotechnology Antibody,Autoimmune,Therapy,FcRn,Ig..	55.5B	71.1%	-	80.9%	38.2	38.8%
HLN Haleon	Biotechnology Toothpaste, Vitamins, Pain-Relief	44.0B	52.5%	53.3%	46.6%	21.8	-7.80%
INSM Insmed	Biotechnology Inhaled Antibiotic, DPP1	41.2B	33.8%	-	86.3%	-	146%
ONC BeiGene	Biotechnology BTK-Inhibitor, Anti-PD-1	38.7B	63.7%	-	67.0%	659	60.8%
NTRA Natera	Biotechnology Prenatal Screening, Carrier	27.7B	47.3%	-	67.8%	-	20.1%
22UA BioNTech SE	Biotechnology Cancer Vaccines, mRNA Therapies	25.1B	21.7%	1.0%	-62.8%	-	-20.2%
BNTX BioNTech SE	Biotechnology Oncology Vaccines,Checkpoint	24.7B	17.6%	1.0%	-49.0%	-	-15.1%
BIIB Biogen	Biotechnology Multiple Sclerosis Therapies	24.6B	71.9%	-	-39.5%	15.3	-3.61%
UTHR United Therapeutics	Biotechnology Treprostinil, Treprostinil	20.1B	92.5%	-	65.2%	17.7	16.5%
INCY Incyte	Biotechnology JAKAFI, MONJUVI, PEMAZYRE	19.9B	90.1%	-	34.4%	17.2	28.1%
GMAB Genmab AS	Biotechnology Antibody, Cancer, Lymphoma	18.8B	82.2%	-	-2.48%	13.3	31.3%
BIM Biomerieux	Biotechnology Diagnostic, Instruments, Reagents	14.8B	80.4%	61.2%	26.9%	33.9	-2.35%
NBIX Neurocrine	Biotechnology Movement, Endocrine	14.4B	85.0%	-	35.1%	34.6	0.78%
ROIV Roivant Sciences	Biotechnology Antibody, Small-Molecule, Inhaled	14.3B	29.0%	-	81.5%	-	57.7%
EXAS EXACT Sciences	Biotechnology Colorectal, Breast, Colon	13.2B	46.3%	-	34.8%	-	70.8%
ASND Ascendis Pharma AS	Biotechnology Growth Hormone	12.6B	36.0%	-	78.5%	-	50.6%
BBIO BridgeBio Pharma	Biotechnology ATTR Medication, FGFR Inhibitor	12.5B	50.8%	-	83.1%	-	151%
RVMD Revolution	Biotechnology RAS Inhibitors, Companion	12.4B	25.2%	-	57.5%	-	9.47%
SMMT Summit Therapeutics	Biotechnology Antibody, Immunotherapy, Oncology	12.3B	47.2%	-	55.1%	-	-21.0%
ERF Eurofins	Biotechnology Testing, Laboratory, Services	12.2B	70.5%	2.79%	15.3%	26.0	13.1%
IONS Ionis	Biotechnology Triglyceride, Amyloidosis, SMA	12.1B	24.3%	0.21%	65.2%	-	84.7%
MDGL Madrigal	Biotechnology Rezdiffra, Liver Therapy, MASH	12.0B	57.3%	-	82.0%	-	52.9%
EXEL Exelixis	Biotechnology Cabozantinib, Cobimetinib	11.3B	93.7%	-	80.7%	17.7	7.80%
BMRN Biomarin	Biotechnology Enzyme replacement therapy	10.4B	85.5%	-	-70.2%	20.1	-25.0%
MRNA Moderna	Biotechnology Respiratory Vaccines, Latent	9.75B	26.0%	-	-85.9%	-	-45.9%
HALO Halozyme	Biotechnology Enzyme, Cancer, Immunodeficiency	8.26B	92.1%	-	51.8%	14.8	34.8%
ABVX Abivax American	Biotechnology Obefazimod, Immunoregulatory	8.19B	38.7%	-	75.3%	-	1,140%
ABVX Abivax	Biotechnology Drug, Phase3, Ulcerative, Crohns	8.07B	39.0%	-	67.8%	-	1,071%
CYTK Cytokinetics	Biotechnology Cardiac Activator, Skeletal	8.01B	43.4%	-	38.2%	-	13.9%
GRFS Grifols	Biotechnology Immunoglobulin, Albumin	7.65B	67.9%	41.9%	14.4%	13.8	-10.9%
MTSR Metsera, Common	Biotechnology Injectable, Oral, Obesity, Peptides	7.43B	49.1%	-	91.2%	-	250%
MRUS Merus BV	Biotechnology Bispecific Antibodies, BIZENGRI	7.29B	31.2%	-	91.7%	-	99.9%
NUVL Nuvalent	Biotechnology ROS1 Inhibitor, ALK Inhibitor	6.89B	25.4%	-	64.1%	-	5.92%
RYTM Rhythm	Biotechnology Setmelanotide, Rare Obesity, MC4R	6.63B	43.2%	-	92.7%	-	51.6%
RGC Regencell	Biotechnology Traditional Chinese Medicine	6.43B	36.4%	-	78.7%	-	7,422%
PTCT PTC Therapeutics	Biotechnology Translarna, Emflaza, Upstaza	6.07B	64.5%	-	59.3%	8.93	62.9%
PCVX Vaxcyte	Biotechnology Pneumococcal, Streptococcus	5.96B	26.7%	-	-11.8%	-	-50.4%
KRYS Krystal Biotech	Biotechnology Gene, Therapy, Topical, Wound, Skin	5.93B	89.1%	-	61.8%	30.7	2.52%
ARWR Arrowhead	Biotechnology Plozasiran, Olpasiran, Fazirsiran	5.70B	34.9%	-	20.6%	-	82.0%
LEGN Legend Biotech	Biotechnology CAR-T, Oncology, Myeloma	5.43B	32.1%	-	-48.8%	-	-38.7%
PTGX Protagonist	Biotechnology Peptide, Hematology, Inflammation	5.20B	64.2%	-	89.1%	126	85.2%
ACLX Arcellx	Biotechnology Anitocabtagene Autoleucel	5.20B	32.4%	-	68.4%	-	-8.19%
COGT Cogent Biosciences	Biotechnology Kinase Inhibitor, FGFR Inhibitor	5.19B	47.7%	-	63.3%	-	242%
TGTX TG Therapeutics	Biotechnology Anti-CD20 Antibody, BTK Inhibitor	4.92B	66.3%	-	38.6%	11.2	-12.6%
CRSP Crispr Therapeutics	Biotechnology Gene-Edited Cell Therapy, CAR T	4.87B	27.2%	-	3.42%	-	-6.75%
ALKS Alkermes	Biotechnology Schizophrenia, Bipolar, Alcohol	4.83B	86.5%	-	11.4%	14.6	-9.70%
KYMR Kymera Therapeutics	Biotechnology IRAK4, STAT6, TYK2, Protein	4.58B	27.4%	-	58.5%	-	31.2%
PRAX Praxis Precision	Biotechnology Ulixacaltamide, Vormatrigine	4.45B	28.0%	-	45.6%	-	99.1%
APGE Apogee	Biotechnology Monoclonal Antibody, Atopic	4.43B	35.0%	-	60.4%	-	25.8%
NAMS NewAmsterdam	Biotechnology Obicetrapib, Ezetimibe, CETP	4.35B	33.6%	-	79.7%	-	68.5%
VKTX Viking Therapeutics	Biotechnology VK2809, VK2735, VK5211, VK0214	4.27B	39.5%	-	41.2%	-	-40.5%
IMVT Immunovant	Biotechnology Monoclonal Antibodies, Autoimmune	4.16B	25.3%	-	16.8%	-	-22.1%
BLTE Belite Bio	Biotechnology Oral Therapy, Stargardt	4.08B	32.9%	-	80.6%	-	18.3%
ACAD ACADIA	Biotechnology Parkinsons Psychosis Drug, Rett	4.06B	85.8%	-	48.7%	15.3	25.8%
CRNX Crinetics	Biotechnology Paltusotine, Atumelnant, CRN09682	4.05B	22.7%	-	35.1%	-	-33.1%
INDV Indivior Ordinary	Biotechnology Suboxone, Sublocade, Subutex, Opvee	4.03B	74.7%	2.63%	82.8%	32.9	168%
CNTA Centessa	Biotechnology Sleep Disorder Drug	4.03B	30.3%	-	70.1%	-	47.1%
LGND Ligand	Biotechnology Infectious, Oncology, Nephrology	3.96B	56.6%	0.14%	81.9%	88.7	59.5%
ADMA ADMA Biologics	Biotechnology IVIG, Immune Globulin, Hepatitis	3.70B	84.7%	-	37.5%	18.1	-31.6%
CELC Celcuity	Biotechnology Cancer Test, Therapy Candidate	3.65B	25.0%	-	77.3%	-	558%
SRRK Scholar Rock	Biotechnology Monoclonal Antibodies, Inhibitor	3.60B	22.5%	-	40.3%	-	22.0%
MIRM Mirum	Biotechnology LIVMARLI, Cholbam, Chenodal	3.56B	48.4%	-	91.7%	-	41.5%
MLYS Mineralys	Biotechnology Phase II Inhibitor, Oral	3.51B	31.0%	-	73.5%	-	197%
IRON Disc Medicine	Biotechnology Porphyria Drug, Anemia Drug	3.40B	29.3%	-	42.5%	-	29.1%
CDTX Cidara Therapeutics	Biotechnology Antifungal, Antiviral, Oncology	3.33B	22.1%	-	77.7%	-	1,198%
RARE Ultragenyx	Biotechnology Biologic, Gene Therapy, Antibody	3.19B	36.4%	-	-54.6%	-	-39.9%
VCYT Veracyte	Biotechnology Thyroid, Prostate, Bladder	3.15B	64.3%	-	11.8%	106	-6.83%
KNSA Kiniksa	Biotechnology ARCALYST, Vixarelimab, KPL-387	3.13B	68.5%	-	92.9%	91.7	74.9%
XENE Xenon	Biotechnology Kv7 Opener, Phase 3, Epilepsy	3.09B	32.9%	-	19.4%	-	-8.48%
TVTX Travere	Biotechnology Medication, Tablets, Enzyme	3.03B	30.4%	-	39.5%	-	73.9%
GRAL GRAIL	Biotechnology Cancer Screening, Diagnostic Aid	3.00B	40.2%	-	91.5%	-	407%
DYN Dyne Therapeutics	Biotechnology Therapeutics, Muscular Dystrophy	2.94B	28.5%	-	19.3%	-	-40.0%
IDYA Ideaya Biosciences	Biotechnology Oncology, Kinase, Inhibitor, ADC	2.90B	24.9%	-	56.4%	-	16.1%
CGON CG Oncology	Biotechnology Oncolytic Immunotherapy	2.88B	30.7%	-	15.7%	-	12.9%
CPRX Catalyst	Biotechnology Firdapse, Fycompa, Ruzurgi, Agamree	2.83B	91.0%	-	21.1%	13.5	-3.75%
ARQT Arcutis	Biotechnology Topical Cream, Topical Foam, JAK1	2.80B	41.4%	-	43.4%	-	140%
VRDN Viridian	Biotechnology Monoclonal Antibody, Thyroid Eye	2.77B	50.3%	-	29.7%	-	33.1%
DNLI Denali Therapeutics	Biotechnology RIPK1 Inhibitor, LRRK2 Inhibitor	2.56B	25.5%	-	-65.1%	-	-37.2%
AGIO Agios Pharm	Biotechnology Mitapivat, Tebapivat, AG-181	2.55B	35.9%	-	-12.6%	-	-59.8%
SLNO Soleno Therapeutics	Biotechnology Diazoxide, Choline, Tablet, Rare	2.54B	41.7%	-	61.2%	-	-26.7%
APLS Apellis	Biotechnology Therapeutic, Complement	2.51B	76.0%	-	-63.9%	55.0	-36.5%
RCUS Arcus Biosciences	Biotechnology HIF-2a-Inhibitor	2.47B	34.0%	-	-15.2%	-	29.8%
ZLAB Zai Lab	Biotechnology Oncology, Immunology	2.46B	29.7%	-	-40.8%	-	-31.1%
EWTX Edgewise	Biotechnology Muscle Disorder Therapies	2.41B	30.4%	-	8.69%	-	-37.7%
FOLD Amicus Therapeutics	Biotechnology Galafold, Pombiliti, Opfolda, Gene	2.35B	53.6%	-	-31.4%	-	-11.9%
NNNN Anbio	Biotechnology Antigen Tests, Immunoassay	2.32B	66.8%	-	85.7%	858	329%
RXRX Recursion	Biotechnology Drug Discovery Platform	2.26B	26.5%	-	-72.9%	-	-43.0%
BEAM Beam Therapeutics	Biotechnology Base-Editing Therapeutics, Sickle	2.20B	26.2%	-	-63.3%	-	-24.8%
GLPG Galapagos	Biotechnology CAR-T, Oncology, Immunology	2.18B	27.1%	-	-14.8%	-	-4.93%
GLPG Galapagos	Biotechnology Medicine, Oncology, Immunology	2.16B	40.1%	-	-2.18%	-	5.45%
GPCR Structure	Biotechnology GSBR-1290, ACCG-2671, ANPA-0073	2.12B	30.2%	-	27.2%	-	-6.14%
IBRX Immunitybio	Biotechnology Immunotherapy, Vaccine, Cytokine	2.05B	66.8%	-	-75.0%	-	-63.0%
AUPH Aurinia	Biotechnology Immunosuppressant, Lupus	2.02B	94.3%	-	59.5%	27.4	64.3%
VCEL Vericel Ord	Biotechnology Cartilage, Skin, Burn, Autologous	2.02B	60.3%	-	-1.51%	153	-40.9%
MESO Mesoblast	Biotechnology Stem-Cell Therapy, Inflammation	1.94B	31.7%	-	38.3%	-	23.9%
ZBIO Zenas BioPharma	Biotechnology Bifunctional Monoclonal Antibody	1.91B	31.4%	-	82.1%	2.61	150%
QURE Uniqure	Biotechnology Gene Therapy, Hemophilia Treatment	1.89B	35.4%	-	19.0%	-	338%
SRPT Sarepta	Biotechnology RNA Therapeutics, Duchenne	1.83B	29.0%	-	-77.5%	-	-86.7%
SYRE Spyre Therapeutics	Biotechnology Monoclonal Antibodies	1.82B	30.4%	-	-34.7%	-	-23.7%
VERA Vera Therapeutics	Biotechnology Atacicept, Mab, Dual-Inhibitor	1.81B	22.9%	3.50%	12.0%	-	-45.5%
TWST Twist Bioscience	Biotechnology Synthetic DNA, Gene Fragments	1.80B	38.1%	-	-40.8%	-	-43.3%
IMCR Immunocore Holdings	Biotechnology Oncology Immunotherapy	1.79B	43.2%	-	-0.83%	-	7.58%
JANX Janux Therapeutics	Biotechnology JANX007, JANX008, TRACTr, TRACIr	1.76B	28.4%	-	3.62%	-	-47.8%
ALVO Alvotech	Biotechnology Biosimilar, Autoimmune, Oncology	1.72B	52.5%	-	-45.6%	24.0	-63.6%
NUVB Nuvation Bio	Biotechnology Oncology Pipeline Drug Candidates	1.61B	34.1%	-	58.0%	-	143%
CLDX Celldex	Biotechnology Monoclonal Antibody, Bispecific	1.58B	37.7%	-	-21.4%	-	-15.1%
IMNM Immunome	Biotechnology Antibody, Oncology, Bispecific	1.57B	41.4%	-	59.3%	-	67.8%
PHVS Pharvaris BV	Biotechnology Bradykinin, Antagonist	1.56B	30.7%	-	69.9%	-	5.54%
MNKD MannKind	Biotechnology Inhaled Insulin, Insulin Delivery	1.56B	64.2%	-	-10.1%	50.7	-35.4%
DNTH Dianthus	Biotechnology Monoclonal Antibody, DNTH103	1.52B	28.1%	-	43.3%	-	73.9%
STOK Stoke Therapeutics	Biotechnology STK-002,Zorevunersen,ASOs,TANGO,Gen..	1.49B	73.4%	-	63.7%	38.3	121%
MEDCL Medincell	Biotechnology Schizophrenia, Postoperative Pain	1.47B	54.7%	-	79.9%	-	49.1%
BCRX BioCryst	Biotechnology Antiviral Injection, Oral HAE	1.47B	72.4%	-	-38.2%	-	-13.9%
SNDX Syndax	Biotechnology Menin Inhibitor, CSF-1R Antibody	1.45B	40.0%	-	-16.9%	-	-4.43%
ATAI ATAI Life Sciences	Biotechnology Psychedelic, Intranasal, Oral	1.44B	37.7%	-	34.3%	-	106%
ARDX Ardelyx	Biotechnology IBS-C Therapy, Phosphate	1.42B	30.0%	-	46.1%	-	0.85%
PGEN Precigen	Biotechnology UltraCAR-T, AdenoVerse, PRGN-3005	1.36B	27.9%	-	55.7%	-	317%
ZYME Zymeworks Common	Biotechnology Zanidatamab, Bispecific Antibody	1.36B	35.0%	-	64.6%	-	46.4%
ORKA Oruka Therapeutics	Biotechnology Monoclonal Antibody	1.33B	29.6%	1.0%	42.5%	-	8.70%
DVAX Dynavax	Biotechnology Hepatitis Vaccine, Adjuvant	1.31B	45.5%	-	-33.4%	-	-20.7%
NRIX Nurix Therapeutics	Biotechnology BTK Degrader, IRAK4 Degrader	1.29B	30.8%	-	-24.6%	-	-39.5%
UPB Upstream Bio	Biotechnology Verekitug, Asthma, Rhinosinusitis	1.26B	38.0%	-	54.1%	-	23.9%
CVAC CureVac	Biotechnology MRNA Vaccines, Oncology Therapies	1.19B	85.0%	-	0.69%	5.28	83.8%
ORIC Oric	Biotechnology ORIC-114, ORIC-944, ORIC-533	1.18B	33.8%	-	61.0%	-	17.4%
PHARM Pharming	Biotechnology RUCONEST, Joenja, OTL-105	1.15B	69.6%	-	47.4%	-	84.8%
IMTX Immatics	Biotechnology TCR-Engineered Cell Therapy, TCR	1.15B	25.8%	-	12.2%	-	15.8%
NVAX Novavax	Biotechnology Vaccine, Adjuvant, Nanoparticle	1.15B	40.5%	-	-52.9%	3.51	-31.0%
MNMD Mind Medicine	Biotechnology MM120, MM402, Anxiety, ADHD, Autism	1.15B	29.0%	-	66.6%	-	29.4%
URGN UroGen Pharma	Biotechnology Jelmyto, UGN-102, UGN-103	1.12B	46.5%	-	67.8%	-	94.0%
RLAY Relay Therapeutics	Biotechnology PI3Ka Inhibitor, Estrogen	1.12B	46.9%	-	-39.3%	-	22.4%
MBX MBX Biosciences	Biotechnology Hypoparathyroidism, Hypoglycemia	1.11B	31.6%	-	51.6%	3.23	48.8%
OCS Oculis Holding	Biotechnology OCS-01, OCS-02, OCS-05	1.11B	23.8%	-	60.1%	-	15.2%
ABCL Abcellera Biologics	Biotechnology Antibody, Metabolic, Autoimmune	1.10B	19.3%	-	-22.9%	-	14.2%
MDXG MiMedx	Biotechnology Placental Allografts, Wound Care	1.10B	83.7%	-	11.9%	27.3	-35.4%
TSHA Taysha Gene	Biotechnology Gene, Therapy, AAV, CNS, Monogenic	1.10B	36.1%	-	50.4%	-	77.5%
NBTX Nanobiotix	Biotechnology Nanoparticles, Radiotherapy	1.06B	46.2%	-	75.8%	-	348%
TNGX Tango Therapeutics	Biotechnology PRMT5 Inhibitor, Glioblastoma	1.04B	33.8%	-	31.5%	-	95.0%
NANO Nanobiotix S.A	Biotechnology Nanoparticle, Radiotherapy	1.02B	41.7%	-	73.7%	-	356%
NTLA Intellia	Biotechnology In-Vivo CRISPR, CAR-T, NK Cell	1.01B	34.1%	-	-64.1%	-	-45.2%
XNCR Xencor	Biotechnology Engineered Monoclonal Antibodies	999M	18.3%	-	-67.1%	-	-41.3%
KOD Kodiak Sciences	Biotechnology Anti-VEGF, Biopolymer Conjugate	997M	34.8%	-	44.5%	-	203%
CSTL Castle Biosciences	Biotechnology Melanoma, Squamous, Uveal	996M	53.7%	-	18.9%	-	12.3%
OPK Opko Health	Biotechnology Diagnostics, Laboratory-Testing	983M	20.6%	-	-40.3%	-	-26.4%
IOVA Iovance	Biotechnology Amtagvi, Proleukin, Lifileucel	981M	42.7%	-	-81.6%	-	-76.1%
KURA Kura Oncology	Biotechnology Menin Inhibitor, Farnesyl	975M	54.0%	-	-33.5%	-	-38.3%
SANA Sana Biotechnology	Biotechnology Allogeneic Islet Therapy, CAR-T	975M	33.9%	-	-4.90%	-	14.1%
PVLA Palvella	Biotechnology Topical Rapamycin Gel, Microcystic	953M	25.7%	-	31.6%	-	411%
ANAB AnaptysBio	Biotechnology Antibody, Autoimmune	936M	24.6%	-	42.3%	-	65.8%
GLUE Monte Rosa	Biotechnology MRT-2359, MRT-6160, MRT-8102, CDK2	935M	71.6%	-	22.1%	44.9	44.6%
RZLT Rezolute	Biotechnology Antibody, Hyperinsulinism	915M	35.0%	-	70.5%	-	72.2%
DAWN Day One	Biotechnology Tovorafenib, DAY301, VRK1 Inhibitor	909M	31.3%	-	-72.8%	-	-45.6%
MLTX MoonLake	Biotechnology Nanobody, IL-17A, IL-17F	905M	25.8%	-	10.1%	-	-76.7%
SVRA Savara	Biotechnology Molgramostim, Proteinosis	875M	21.8%	-	71.2%	-	33.4%
ABUS Arbutus Biopharma	Biotechnology RNAi Therapeutic, PD-L1 Inhibitor	874M	30.8%	-	50.0%	-	9.16%
GHRS GH Research	Biotechnology Mebufotenin, Depression	868M	27.0%	-	30.2%	-	14.2%
LENZ LENZ Therapeutics	Biotechnology Ophthalmic, Presbyopia, Clinical	867M	39.4%	1.0%	15.8%	-	-26.9%
CMPX Compass	Biotechnology Tovecimig, CTX-471, CTX-8371	859M	28.3%	-	32.0%	-	217%
BHVN Biohaven	Biotechnology Troriluzole, Taldefgrobep	855M	36.5%	-	-59.4%	-	-81.6%
AVBP ArriVent	Biotechnology Firmonertinib, ARR-217, ARR-002	854M	40.1%	-	-19.4%	-	-34.6%
TYRA Tyra Biosciences	Biotechnology Precision Medicine Platform, FGFR	840M	28.3%	-	49.0%	-	18.3%
SPRY ARS	Biotechnology Epinephrine, Nasal Spray	831M	26.6%	-	-11.8%	-	-55.6%
BCAX Bicara	Biotechnology Ficerafusp Alfa, Bifunctional	824M	29.8%	-	-33.4%	2.80	-21.3%
CDNA CareDx	Biotechnology AlloSure, AlloMap, AlloSeq	820M	52.7%	-	-31.6%	12.5	-37.0%
ORGO Organogenesis	Biotechnology Wound Care, Surgical Matrix	788M	33.3%	-	43.0%	-	15.3%
VIR Vir Biotechnology	Biotechnology HDV, RSV, HPV, Coronavirus, TCE	783M	29.9%	-	-79.3%	-	-26.3%
RAPT RAPT Therapeutics	Biotechnology CCR4 Antagonist, Inflammation	770M	29.2%	-	-26.2%	-	192%
VLA Valneva SE	Biotechnology Japanese Encephalitis, Cholera	770M	18.0%	-	-6.87%	-	59.1%
SION Sionna	Biotechnology Galicaftor, Navocaftor, SION-109	769M	33.9%	-	90.7%	-	99.3%
GERN Geron	Biotechnology Telomerase Inhibitor	737M	28.8%	-	-65.7%	-	-75.4%
RIGL Rigel	Biotechnology Kinase, Inhibitor	725M	92.6%	-	67.0%	6.45	61.2%
ERAS Erasca	Biotechnology Naporafenib, ERAS-0015, ERAS-4001	721M	33.5%	-	-43.0%	-	-5.85%
ATXS Astria Therapeutics	Biotechnology Monoclonal, Antibody, Plasma	710M	33.9%	-	17.8%	-	16.2%
REPL Replimune	Biotechnology Oncolytic Immunotherapy, RP1, RP2	705M	28.0%	-	-73.3%	-	-28.3%
ESPR Esperion	Biotechnology Cholesterol-Lowering Tablets	702M	53.4%	-	-29.3%	-	9.44%
LXEO Lexeo	Biotechnology Gene Therapy, Cardiomyopathy	692M	34.7%	-	-10.5%	-	30.2%
KALV Kalvista	Biotechnology Plasma Kallikrein Inhibitors, Oral	688M	37.6%	-	61.7%	-	29.9%
MGTX MeiraGTx Holdings	Biotechnology Gene Therapies, Retinal Diseases	666M	32.6%	-	25.9%	-	14.1%
CRVS Corvus	Biotechnology Kinase Inhibitor, Adenosine	665M	32.1%	-	51.3%	-	-7.66%
CTMX CytomX Therapeutics	Biotechnology Antibody-Drug Conjugate, T-Cell	657M	60.1%	-	50.1%	12.9	287%
PROK ProKidney	Biotechnology Cell Therapy, Renal Cells	629M	42.5%	-	-25.1%	-	13.3%
GOSS Gossamer Bio	Biotechnology Seralutinib, GB002, PAH Therapy	627M	34.5%	-	-5.28%	-	299%
VSTM Verastem	Biotechnology Avutometinib, Defactinib	611M	39.6%	-	48.2%	-	131%
PRME Prime Medicine	Biotechnology Gene Editing, Prime Editing	608M	40.5%	-	-29.4%	-	10.3%
MYGN Myriad Genetics	Biotechnology Hereditary Cancer, Companion	600M	35.5%	0.08%	-77.8%	-	-59.7%
IVA Inventiva S.A	Biotechnology Lanifibranor, Odiparcil, TGF-Beta	598M	43.3%	-	15.0%	-	25.1%
RGNX Regenxbio	Biotechnology Gene,Therapy,AAV,Platform,Pipeline	589M	22.3%	-	-25.6%	-	0.92%
FDMT 4D Molecular	Biotechnology Ophthalmology, Cystic-Fibrosis	587M	25.1%	-	-23.4%	-	9.92%
OLMA Olema	Biotechnology Palazestrant, OP-3136, KAT6	577M	32.2%	-	57.5%	-	138%
ASMB Assembly	Biotechnology Antiviral, Small-Molecule	575M	34.4%	-	56.2%	-	119%
IVA Inventiva	Biotechnology Lanifibranor, Odiparcil, TGF-Beta	557M	46.0%	-	25.2%	-	26.6%
MNPR Monopar	Biotechnology Cancer Therapeutics, Monoclonal	555M	26.6%	-	73.7%	-	291%
ALMS Alumis	Biotechnology TYK2 Inhibitor, Psoriasis, Lupus	549M	56.0%	-	-79.1%	0.16	-35.8%
PRTA Prothena	Biotechnology Neurodegeneration, Antibody	548M	25.4%	-	-73.9%	-	-37.6%
LXRX Lexicon	Biotechnology Sotagliflozin, LX9211, LX9851	541M	36.7%	-	-4.79%	-	46.2%

ABBV
AbbVie

Biotechnology
Biologics, Immunology, Oncology

411B

50.7%

68.9%

87.0%

176

26.6%

AMGN
Amgen

Biotechnology
Rheumatoid Arthritis, Psoriasis

181B

82.4%

67.9%

52.5%

26.0

7.01%

GILD
Gilead Sciences

Biotechnology
Antivirals, Oncology, Hepatitis

155B

83.5%

65.5%

86.9%

19.4

29.8%

VRTX
Vertex

Biotechnology
Cystic Fibrosis, Sickle Cell, Beta

110B

87.3%

-

20.8%

30.6

-16.3%

REGN
Regeneron

Biotechnology
Eylea, Dupixent, Libtayo

73.0B

79.6%

14.9%

-17.4%

16.7

-16.4%

ALNY
Alnylam

Biotechnology
RNAi Therapeutics, Patisiran

60.0B

60.3%

-

86.8%

-

60.2%

ARGX
argenx

Biotechnology
Antibody,Autoimmune,Therapy,FcRn,Ig..

55.5B

71.1%

-

80.9%

38.2

38.8%

HLN
Haleon

Biotechnology
Toothpaste, Vitamins, Pain-Relief

44.0B

52.5%

53.3%

46.6%

21.8

-7.80%

INSM
Insmed

Biotechnology
Inhaled Antibiotic, DPP1

41.2B

33.8%

-

86.3%

-

146%

ONC
BeiGene

Biotechnology
BTK-Inhibitor, Anti-PD-1

38.7B

63.7%

-

67.0%

659

60.8%

NTRA
Natera

Biotechnology
Prenatal Screening, Carrier

27.7B

47.3%

-

67.8%

-

20.1%

22UA
BioNTech SE

Biotechnology
Cancer Vaccines, mRNA Therapies

25.1B

21.7%

1.0%

-62.8%

-

-20.2%

BNTX
BioNTech SE

Biotechnology
Oncology Vaccines,Checkpoint

24.7B

17.6%

1.0%

-49.0%

-

-15.1%

BIIB
Biogen

Biotechnology
Multiple Sclerosis Therapies

24.6B

71.9%

-

-39.5%

15.3

-3.61%

UTHR
United Therapeutics

Biotechnology
Treprostinil, Treprostinil

20.1B

92.5%

-

65.2%

17.7

16.5%

INCY
Incyte

Biotechnology
JAKAFI, MONJUVI, PEMAZYRE

19.9B

90.1%

-

34.4%

17.2

28.1%

GMAB
Genmab AS

Biotechnology
Antibody, Cancer, Lymphoma

18.8B

82.2%

-

-2.48%

13.3

31.3%

BIM
Biomerieux

Biotechnology
Diagnostic, Instruments, Reagents

14.8B

80.4%

61.2%

26.9%

33.9

-2.35%

NBIX
Neurocrine

Biotechnology
Movement, Endocrine

14.4B

85.0%

-

35.1%

34.6

0.78%

ROIV
Roivant Sciences

Biotechnology
Antibody, Small-Molecule, Inhaled

14.3B

29.0%

-

81.5%

-

57.7%

EXAS
EXACT Sciences

Biotechnology
Colorectal, Breast, Colon

13.2B

46.3%

-

34.8%

-

70.8%

ASND
Ascendis Pharma AS

Biotechnology
Growth Hormone

12.6B

36.0%

-

78.5%

-

50.6%

BBIO
BridgeBio Pharma

Biotechnology
ATTR Medication, FGFR Inhibitor

12.5B

50.8%

-

83.1%

-

151%

RVMD
Revolution

Biotechnology
RAS Inhibitors, Companion

12.4B

25.2%

-

57.5%

-

9.47%

SMMT
Summit Therapeutics

Biotechnology
Antibody, Immunotherapy, Oncology

12.3B

47.2%

-

55.1%

-

-21.0%

ERF
Eurofins

Biotechnology
Testing, Laboratory, Services

12.2B

70.5%

2.79%

15.3%

26.0

13.1%

IONS
Ionis

Biotechnology
Triglyceride, Amyloidosis, SMA

12.1B

24.3%

0.21%

65.2%

-

84.7%

MDGL
Madrigal

Biotechnology
Rezdiffra, Liver Therapy, MASH

12.0B

57.3%

-

82.0%

-

52.9%

EXEL
Exelixis

Biotechnology
Cabozantinib, Cobimetinib

11.3B

93.7%

-

80.7%

17.7

7.80%

BMRN
Biomarin

Biotechnology
Enzyme replacement therapy

10.4B

85.5%

-

-70.2%

20.1

-25.0%

MRNA
Moderna

Biotechnology
Respiratory Vaccines, Latent

9.75B

26.0%

-

-85.9%

-

-45.9%

HALO
Halozyme

Biotechnology
Enzyme, Cancer, Immunodeficiency

8.26B

92.1%

-

51.8%

14.8

34.8%

ABVX
Abivax American

Biotechnology
Obefazimod, Immunoregulatory

8.19B

38.7%

-

75.3%

-

1,140%

ABVX
Abivax

Biotechnology
Drug, Phase3, Ulcerative, Crohns

8.07B

39.0%

-

67.8%

-

1,071%

CYTK
Cytokinetics

Biotechnology
Cardiac Activator, Skeletal

8.01B

43.4%

-

38.2%

-

13.9%

GRFS
Grifols

Biotechnology
Immunoglobulin, Albumin

7.65B

67.9%

41.9%

14.4%

13.8

-10.9%

MTSR
Metsera, Common

Biotechnology
Injectable, Oral, Obesity, Peptides

7.43B

49.1%

-

91.2%

-

250%

MRUS
Merus BV

Biotechnology
Bispecific Antibodies, BIZENGRI

7.29B

31.2%

-

91.7%

-

99.9%

NUVL
Nuvalent

Biotechnology
ROS1 Inhibitor, ALK Inhibitor

6.89B

25.4%

-

64.1%

-

5.92%

RYTM
Rhythm

Biotechnology
Setmelanotide, Rare Obesity, MC4R

6.63B

43.2%

-

92.7%

-

51.6%

RGC
Regencell

Biotechnology
Traditional Chinese Medicine

6.43B

36.4%

-

78.7%

-

7,422%

PTCT
PTC Therapeutics

Biotechnology
Translarna, Emflaza, Upstaza

6.07B

64.5%

-

59.3%

8.93

62.9%

PCVX
Vaxcyte

Biotechnology
Pneumococcal, Streptococcus

5.96B

26.7%

-

-11.8%

-

-50.4%

KRYS
Krystal Biotech

Biotechnology
Gene, Therapy, Topical, Wound, Skin

5.93B

89.1%

-

61.8%

30.7

2.52%

ARWR
Arrowhead

Biotechnology
Plozasiran, Olpasiran, Fazirsiran

5.70B

34.9%

-

20.6%

-

82.0%

LEGN
Legend Biotech

Biotechnology
CAR-T, Oncology, Myeloma

5.43B

32.1%

-

-48.8%

-

-38.7%

PTGX
Protagonist

Biotechnology
Peptide, Hematology, Inflammation

5.20B

64.2%

-

89.1%

126

85.2%

ACLX
Arcellx

Biotechnology
Anitocabtagene Autoleucel

5.20B

32.4%

-

68.4%

-

-8.19%

COGT
Cogent Biosciences

Biotechnology
Kinase Inhibitor, FGFR Inhibitor

5.19B

47.7%

-

63.3%

-

242%

TGTX
TG Therapeutics

Biotechnology
Anti-CD20 Antibody, BTK Inhibitor

4.92B

66.3%

-

38.6%

11.2

-12.6%

CRSP
Crispr Therapeutics

Biotechnology
Gene-Edited Cell Therapy, CAR T

4.87B

27.2%

-

3.42%

-

-6.75%

ALKS
Alkermes

Biotechnology
Schizophrenia, Bipolar, Alcohol

4.83B

86.5%

-

11.4%

14.6

-9.70%

KYMR
Kymera Therapeutics

Biotechnology
IRAK4, STAT6, TYK2, Protein

4.58B

27.4%

-

58.5%

-

31.2%

PRAX
Praxis Precision

Biotechnology
Ulixacaltamide, Vormatrigine

4.45B

28.0%

-

45.6%

-

99.1%

APGE
Apogee

Biotechnology
Monoclonal Antibody, Atopic

4.43B

35.0%

-

60.4%

-

25.8%

NAMS
NewAmsterdam

Biotechnology
Obicetrapib, Ezetimibe, CETP

4.35B

33.6%

-

79.7%

-

68.5%

VKTX
Viking Therapeutics

Biotechnology
VK2809, VK2735, VK5211, VK0214

4.27B

39.5%

-

41.2%

-

-40.5%

IMVT
Immunovant

Biotechnology
Monoclonal Antibodies, Autoimmune

4.16B

25.3%

-

16.8%

-

-22.1%

BLTE
Belite Bio

Biotechnology
Oral Therapy, Stargardt

4.08B

32.9%

-

80.6%

-

18.3%

ACAD
ACADIA

Biotechnology
Parkinsons Psychosis Drug, Rett

4.06B

85.8%

-

48.7%

15.3

25.8%

CRNX
Crinetics

Biotechnology
Paltusotine, Atumelnant, CRN09682

4.05B

22.7%

-

35.1%

-

-33.1%

INDV
Indivior Ordinary

Biotechnology
Suboxone, Sublocade, Subutex, Opvee

4.03B

74.7%

2.63%

82.8%

32.9

168%

CNTA
Centessa

Biotechnology
Sleep Disorder Drug

4.03B

30.3%

-

70.1%

-

47.1%

LGND
Ligand

Biotechnology
Infectious, Oncology, Nephrology

3.96B

56.6%

0.14%

81.9%

88.7

59.5%

ADMA
ADMA Biologics

Biotechnology
IVIG, Immune Globulin, Hepatitis

3.70B

84.7%

-

37.5%

18.1

-31.6%

CELC
Celcuity

Biotechnology
Cancer Test, Therapy Candidate

3.65B

25.0%

-

77.3%

-

558%

SRRK
Scholar Rock

Biotechnology
Monoclonal Antibodies, Inhibitor

3.60B

22.5%

-

40.3%

-

22.0%

MIRM
Mirum

Biotechnology
LIVMARLI, Cholbam, Chenodal

3.56B

48.4%

-

91.7%

-

41.5%

MLYS
Mineralys

Biotechnology
Phase II Inhibitor, Oral

3.51B

31.0%

-

73.5%

-

197%

IRON
Disc Medicine

Biotechnology
Porphyria Drug, Anemia Drug

3.40B

29.3%

-

42.5%

-

29.1%

CDTX
Cidara Therapeutics

Biotechnology
Antifungal, Antiviral, Oncology

3.33B

22.1%

-

77.7%

-

1,198%

RARE
Ultragenyx

Biotechnology
Biologic, Gene Therapy, Antibody

3.19B

36.4%

-

-54.6%

-

-39.9%

VCYT
Veracyte

Biotechnology
Thyroid, Prostate, Bladder

3.15B

64.3%

-

11.8%

106

-6.83%

KNSA
Kiniksa

Biotechnology
ARCALYST, Vixarelimab, KPL-387

3.13B

68.5%

-

92.9%

91.7

74.9%

XENE
Xenon

Biotechnology
Kv7 Opener, Phase 3, Epilepsy

3.09B

32.9%

-

19.4%

-

-8.48%

TVTX
Travere

Biotechnology
Medication, Tablets, Enzyme

3.03B

30.4%

-

39.5%

-

73.9%

GRAL
GRAIL

Biotechnology
Cancer Screening, Diagnostic Aid

3.00B

40.2%

-

91.5%

-

407%

DYN
Dyne Therapeutics

Biotechnology
Therapeutics, Muscular Dystrophy

2.94B

28.5%

-

19.3%

-

-40.0%

IDYA
Ideaya Biosciences

Biotechnology
Oncology, Kinase, Inhibitor, ADC

2.90B

24.9%

-

56.4%

-

16.1%

CGON
CG Oncology

Biotechnology
Oncolytic Immunotherapy

2.88B

30.7%

-

15.7%

-

12.9%

CPRX
Catalyst

Biotechnology
Firdapse, Fycompa, Ruzurgi, Agamree

2.83B

91.0%

-

21.1%

13.5

-3.75%

ARQT
Arcutis

Biotechnology
Topical Cream, Topical Foam, JAK1

2.80B

41.4%

-

43.4%

-

140%

VRDN
Viridian

Biotechnology
Monoclonal Antibody, Thyroid Eye

2.77B

50.3%

-

29.7%

-

33.1%

DNLI
Denali Therapeutics

Biotechnology
RIPK1 Inhibitor, LRRK2 Inhibitor

2.56B

25.5%

-

-65.1%

-

-37.2%

AGIO
Agios Pharm

Biotechnology
Mitapivat, Tebapivat, AG-181

2.55B

35.9%

-

-12.6%

-

-59.8%

SLNO
Soleno Therapeutics

Biotechnology
Diazoxide, Choline, Tablet, Rare

2.54B

41.7%

-

61.2%

-

-26.7%

APLS
Apellis

Biotechnology
Therapeutic, Complement

2.51B

76.0%

-

-63.9%

55.0

-36.5%

RCUS
Arcus Biosciences

Biotechnology
HIF-2a-Inhibitor

2.47B

34.0%

-

-15.2%

-

29.8%

ZLAB
Zai Lab

Biotechnology
Oncology, Immunology

2.46B

29.7%

-

-40.8%

-

-31.1%

EWTX
Edgewise

Biotechnology
Muscle Disorder Therapies

2.41B

30.4%

-

8.69%

-

-37.7%

FOLD
Amicus Therapeutics

Biotechnology
Galafold, Pombiliti, Opfolda, Gene

2.35B

53.6%

-

-31.4%

-

-11.9%

NNNN
Anbio

Biotechnology
Antigen Tests, Immunoassay

2.32B

66.8%

-

85.7%

858

329%

RXRX
Recursion

Biotechnology
Drug Discovery Platform

2.26B

26.5%

-

-72.9%

-

-43.0%

BEAM
Beam Therapeutics

Biotechnology
Base-Editing Therapeutics, Sickle

2.20B

26.2%

-

-63.3%

-

-24.8%

GLPG
Galapagos

Biotechnology
CAR-T, Oncology, Immunology

2.18B

27.1%

-

-14.8%

-

-4.93%

GLPG
Galapagos

Biotechnology
Medicine, Oncology, Immunology

2.16B

40.1%

-

-2.18%

-

5.45%

GPCR
Structure

Biotechnology
GSBR-1290, ACCG-2671, ANPA-0073

2.12B

30.2%

-

27.2%

-

-6.14%

IBRX
Immunitybio

Biotechnology
Immunotherapy, Vaccine, Cytokine

2.05B

66.8%

-

-75.0%

-

-63.0%

AUPH
Aurinia

Biotechnology
Immunosuppressant, Lupus

2.02B

94.3%

-

59.5%

27.4

64.3%

VCEL
Vericel Ord

Biotechnology
Cartilage, Skin, Burn, Autologous

2.02B

60.3%

-

-1.51%

153

-40.9%

MESO
Mesoblast

Biotechnology
Stem-Cell Therapy, Inflammation

1.94B

31.7%

-

38.3%

-

23.9%

ZBIO
Zenas BioPharma

Biotechnology
Bifunctional Monoclonal Antibody

1.91B

31.4%

-

82.1%

2.61

150%

QURE
Uniqure

Biotechnology
Gene Therapy, Hemophilia Treatment

1.89B

35.4%

-

19.0%

-

338%

SRPT
Sarepta

Biotechnology
RNA Therapeutics, Duchenne

1.83B

29.0%

-

-77.5%

-

-86.7%

SYRE
Spyre Therapeutics

Biotechnology
Monoclonal Antibodies

1.82B

30.4%

-

-34.7%

-

-23.7%

VERA
Vera Therapeutics

Biotechnology
Atacicept, Mab, Dual-Inhibitor

1.81B

22.9%

3.50%

12.0%

-

-45.5%

TWST
Twist Bioscience

Biotechnology
Synthetic DNA, Gene Fragments

1.80B

38.1%

-

-40.8%

-

-43.3%

IMCR
Immunocore Holdings

Biotechnology
Oncology Immunotherapy

1.79B

43.2%

-

-0.83%

-

7.58%

JANX
Janux Therapeutics

Biotechnology
JANX007, JANX008, TRACTr, TRACIr

1.76B

28.4%

-

3.62%

-

-47.8%

ALVO
Alvotech

Biotechnology
Biosimilar, Autoimmune, Oncology

1.72B

52.5%

-

-45.6%

24.0

-63.6%

NUVB
Nuvation Bio

Biotechnology
Oncology Pipeline Drug Candidates

1.61B

34.1%

-

58.0%

-

143%

CLDX
Celldex

Biotechnology
Monoclonal Antibody, Bispecific

1.58B

37.7%

-

-21.4%

-

-15.1%

IMNM
Immunome

Biotechnology
Antibody, Oncology, Bispecific

1.57B

41.4%

-

59.3%

-

67.8%

PHVS
Pharvaris BV

Biotechnology
Bradykinin, Antagonist

1.56B

30.7%

-

69.9%

-

5.54%

MNKD
MannKind

Biotechnology
Inhaled Insulin, Insulin Delivery

1.56B

64.2%

-

-10.1%

50.7

-35.4%

DNTH
Dianthus

Biotechnology
Monoclonal Antibody, DNTH103

1.52B

28.1%

-

43.3%

-

73.9%

STOK
Stoke Therapeutics

Biotechnology
STK-002,Zorevunersen,ASOs,TANGO,Gen..

1.49B

73.4%

-

63.7%

38.3

121%

MEDCL
Medincell

Biotechnology
Schizophrenia, Postoperative Pain

1.47B

54.7%

-

79.9%

-

49.1%

BCRX
BioCryst

Biotechnology
Antiviral Injection, Oral HAE

1.47B

72.4%

-

-38.2%

-

-13.9%

SNDX
Syndax

Biotechnology
Menin Inhibitor, CSF-1R Antibody

1.45B

40.0%

-

-16.9%

-

-4.43%

ATAI
ATAI Life Sciences

Biotechnology
Psychedelic, Intranasal, Oral

1.44B

37.7%

-

34.3%

-

106%

ARDX
Ardelyx

Biotechnology
IBS-C Therapy, Phosphate

1.42B

30.0%

-

46.1%

-

0.85%

PGEN
Precigen

Biotechnology
UltraCAR-T, AdenoVerse, PRGN-3005

1.36B

27.9%

-

55.7%

-

317%

ZYME
Zymeworks Common

Biotechnology
Zanidatamab, Bispecific Antibody

1.36B

35.0%

-

64.6%

-

46.4%

ORKA
Oruka Therapeutics

Biotechnology
Monoclonal Antibody

1.33B

29.6%

1.0%

42.5%

-

8.70%

DVAX
Dynavax

Biotechnology
Hepatitis Vaccine, Adjuvant

1.31B

45.5%

-

-33.4%

-

-20.7%

NRIX
Nurix Therapeutics

Biotechnology
BTK Degrader, IRAK4 Degrader

1.29B

30.8%

-

-24.6%

-

-39.5%

UPB
Upstream Bio

Biotechnology
Verekitug, Asthma, Rhinosinusitis

1.26B

38.0%

-

54.1%

-

23.9%

CVAC
CureVac

Biotechnology
MRNA Vaccines, Oncology Therapies

1.19B

85.0%

-

0.69%

5.28

83.8%

ORIC
Oric

Biotechnology
ORIC-114, ORIC-944, ORIC-533

1.18B

33.8%

-

61.0%

-

17.4%

PHARM
Pharming

Biotechnology
RUCONEST, Joenja, OTL-105

1.15B

69.6%

-

47.4%

-

84.8%

IMTX
Immatics

Biotechnology
TCR-Engineered Cell Therapy, TCR

1.15B

25.8%

-

12.2%

-

15.8%

NVAX
Novavax

Biotechnology
Vaccine, Adjuvant, Nanoparticle

1.15B

40.5%

-

-52.9%

3.51

-31.0%

MNMD
Mind Medicine

Biotechnology
MM120, MM402, Anxiety, ADHD, Autism

1.15B

29.0%

-

66.6%

-

29.4%

URGN
UroGen Pharma

Biotechnology
Jelmyto, UGN-102, UGN-103

1.12B

46.5%

-

67.8%

-

94.0%

RLAY
Relay Therapeutics

Biotechnology
PI3Ka Inhibitor, Estrogen

1.12B

46.9%

-

-39.3%

-

22.4%

MBX
MBX Biosciences

Biotechnology
Hypoparathyroidism, Hypoglycemia

1.11B

31.6%

-

51.6%

3.23

48.8%

OCS
Oculis Holding

Biotechnology
OCS-01, OCS-02, OCS-05

1.11B

23.8%

-

60.1%

-

15.2%

ABCL
Abcellera Biologics

Biotechnology
Antibody, Metabolic, Autoimmune

1.10B

19.3%

-

-22.9%

-

14.2%

MDXG
MiMedx

Biotechnology
Placental Allografts, Wound Care

1.10B

83.7%

-

11.9%

27.3

-35.4%

TSHA
Taysha Gene

Biotechnology
Gene, Therapy, AAV, CNS, Monogenic

1.10B

36.1%

-

50.4%

-

77.5%

NBTX
Nanobiotix

Biotechnology
Nanoparticles, Radiotherapy

1.06B

46.2%

-

75.8%

-

348%

TNGX
Tango Therapeutics

Biotechnology
PRMT5 Inhibitor, Glioblastoma

1.04B

33.8%

-

31.5%

-

95.0%

NANO
Nanobiotix S.A

Biotechnology
Nanoparticle, Radiotherapy

1.02B

41.7%

-

73.7%

-

356%

NTLA
Intellia

Biotechnology
In-Vivo CRISPR, CAR-T, NK Cell

1.01B

34.1%

-

-64.1%

-

-45.2%

XNCR
Xencor

Biotechnology
Engineered Monoclonal Antibodies

999M

18.3%

-

-67.1%

-

-41.3%

KOD
Kodiak Sciences

Biotechnology
Anti-VEGF, Biopolymer Conjugate

997M

34.8%

-

44.5%

-

203%

CSTL
Castle Biosciences

Biotechnology
Melanoma, Squamous, Uveal

996M

53.7%

-

18.9%

-

12.3%

OPK
Opko Health

Biotechnology
Diagnostics, Laboratory-Testing

983M

20.6%

-

-40.3%

-

-26.4%

IOVA
Iovance

Biotechnology
Amtagvi, Proleukin, Lifileucel

981M

42.7%

-

-81.6%

-

-76.1%

KURA
Kura Oncology

Biotechnology
Menin Inhibitor, Farnesyl

975M

54.0%

-

-33.5%

-

-38.3%

SANA
Sana Biotechnology

Biotechnology
Allogeneic Islet Therapy, CAR-T

975M

33.9%

-

-4.90%

-

14.1%

PVLA
Palvella

Biotechnology
Topical Rapamycin Gel, Microcystic

953M

25.7%

-

31.6%

-

411%

ANAB
AnaptysBio

Biotechnology
Antibody, Autoimmune

936M

24.6%

-

42.3%

-

65.8%

GLUE
Monte Rosa

Biotechnology
MRT-2359, MRT-6160, MRT-8102, CDK2

935M

71.6%

-

22.1%

44.9

44.6%

RZLT
Rezolute

Biotechnology
Antibody, Hyperinsulinism

915M

35.0%

-

70.5%

-

72.2%

DAWN
Day One

Biotechnology
Tovorafenib, DAY301, VRK1 Inhibitor

909M

31.3%

-

-72.8%

-

-45.6%

MLTX
MoonLake

Biotechnology
Nanobody, IL-17A, IL-17F

905M

25.8%

-

10.1%

-

-76.7%

SVRA
Savara

Biotechnology
Molgramostim, Proteinosis

875M

21.8%

-

71.2%

-

33.4%

ABUS
Arbutus Biopharma

Biotechnology
RNAi Therapeutic, PD-L1 Inhibitor

874M

30.8%

-

50.0%

-

9.16%

GHRS
GH Research

Biotechnology
Mebufotenin, Depression

868M

27.0%

-

30.2%

-

14.2%

LENZ
LENZ Therapeutics

Biotechnology
Ophthalmic, Presbyopia, Clinical

867M

39.4%

1.0%

15.8%

-

-26.9%

CMPX
Compass

Biotechnology
Tovecimig, CTX-471, CTX-8371

859M

28.3%

-

32.0%

-

217%

BHVN
Biohaven

Biotechnology
Troriluzole, Taldefgrobep

855M

36.5%

-

-59.4%

-

-81.6%

AVBP
ArriVent

Biotechnology
Firmonertinib, ARR-217, ARR-002

854M

40.1%

-

-19.4%

-

-34.6%

TYRA
Tyra Biosciences

Biotechnology
Precision Medicine Platform, FGFR

840M

28.3%

-

49.0%

-

18.3%

SPRY
ARS

Biotechnology
Epinephrine, Nasal Spray

831M

26.6%

-

-11.8%

-

-55.6%

BCAX
Bicara

Biotechnology
Ficerafusp Alfa, Bifunctional

824M

29.8%

-

-33.4%

2.80

-21.3%

CDNA
CareDx

Biotechnology
AlloSure, AlloMap, AlloSeq

820M

52.7%

-

-31.6%

12.5

-37.0%

ORGO
Organogenesis

Biotechnology
Wound Care, Surgical Matrix

788M

33.3%

-

43.0%

-

15.3%

VIR
Vir Biotechnology

Biotechnology
HDV, RSV, HPV, Coronavirus, TCE

783M

29.9%

-

-79.3%

-

-26.3%

RAPT
RAPT Therapeutics

Biotechnology
CCR4 Antagonist, Inflammation

770M

29.2%

-

-26.2%

-

192%

VLA
Valneva SE

Biotechnology
Japanese Encephalitis, Cholera

770M

18.0%

-

-6.87%

-

59.1%

SION
Sionna

Biotechnology
Galicaftor, Navocaftor, SION-109

769M

33.9%

-

90.7%

-

99.3%

GERN
Geron

Biotechnology
Telomerase Inhibitor

737M

28.8%

-

-65.7%

-

-75.4%

RIGL
Rigel

Biotechnology
Kinase, Inhibitor

725M

92.6%

-

67.0%

6.45

61.2%

ERAS
Erasca

Biotechnology
Naporafenib, ERAS-0015, ERAS-4001

721M

33.5%

-

-43.0%

-

-5.85%

ATXS
Astria Therapeutics

Biotechnology
Monoclonal, Antibody, Plasma

710M

33.9%

-

17.8%

-

16.2%

REPL
Replimune

Biotechnology
Oncolytic Immunotherapy, RP1, RP2

705M

28.0%

-

-73.3%

-

-28.3%

ESPR
Esperion

Biotechnology
Cholesterol-Lowering Tablets

702M

53.4%

-

-29.3%

-

9.44%

LXEO
Lexeo

Biotechnology
Gene Therapy, Cardiomyopathy

692M

34.7%

-

-10.5%

-

30.2%

KALV
Kalvista

Biotechnology
Plasma Kallikrein Inhibitors, Oral

688M

37.6%

-

61.7%

-

29.9%

MGTX
MeiraGTx Holdings

Biotechnology
Gene Therapies, Retinal Diseases

666M

32.6%

-

25.9%

-

14.1%

CRVS
Corvus

Biotechnology
Kinase Inhibitor, Adenosine

665M

32.1%

-

51.3%

-

-7.66%

CTMX
CytomX Therapeutics

Biotechnology
Antibody-Drug Conjugate, T-Cell

657M

60.1%

-

50.1%

12.9

287%

PROK
ProKidney

Biotechnology
Cell Therapy, Renal Cells

629M

42.5%

-

-25.1%

-

13.3%

GOSS
Gossamer Bio

Biotechnology
Seralutinib, GB002, PAH Therapy

627M

34.5%

-

-5.28%

-

299%

VSTM
Verastem

Biotechnology
Avutometinib, Defactinib

611M

39.6%

-

48.2%

-

131%

PRME
Prime Medicine

Biotechnology
Gene Editing, Prime Editing

608M

40.5%

-

-29.4%

-

10.3%

MYGN
Myriad Genetics

Biotechnology
Hereditary Cancer, Companion

600M

35.5%

0.08%

-77.8%

-

-59.7%

IVA
Inventiva S.A

Biotechnology
Lanifibranor, Odiparcil, TGF-Beta

598M

43.3%

-

15.0%

-

25.1%

RGNX
Regenxbio

Biotechnology
Gene,Therapy,AAV,Platform,Pipeline

589M

22.3%

-

-25.6%

-

0.92%

FDMT
4D Molecular

Biotechnology
Ophthalmology, Cystic-Fibrosis

587M

25.1%

-

-23.4%

-

9.92%

OLMA
Olema

Biotechnology
Palazestrant, OP-3136, KAT6

577M

32.2%

-

57.5%

-

138%

ASMB
Assembly

Biotechnology
Antiviral, Small-Molecule

575M

34.4%

-

56.2%

-

119%

IVA
Inventiva

Biotechnology
Lanifibranor, Odiparcil, TGF-Beta

557M

46.0%

-

25.2%

-

26.6%

MNPR
Monopar

Biotechnology
Cancer Therapeutics, Monoclonal

555M

26.6%

-

73.7%

-

291%

ALMS
Alumis

Biotechnology
TYK2 Inhibitor, Psoriasis, Lupus

549M

56.0%

-

-79.1%

0.16

-35.8%

PRTA
Prothena

Biotechnology
Neurodegeneration, Antibody

548M

25.4%

-

-73.9%

-

-37.6%

LXRX
Lexicon

Biotechnology
Sotagliflozin, LX9211, LX9851

541M

36.7%

-

-4.79%

-

46.2%

Stocks & ETFs Screener: 200+ results (Biotechnology)

Basic Filter

Fundamental Filter

Benchmark

Performance/Technical